Healthcare 2047: Challenges, Priorities and an Action Agenda

Executive summary

A developed India needs strong primary care, prevention, quality treatment and protection against catastrophic health costs. Invest in frontline primary care; chronic-disease prevention; referral networks; interoperable records with consent; transparent quality measurement. This working paper proposes a phased, measurable agenda for healthcare and identifies evidence that expert contributors should test before a final policy recommendation is published.

1. Problem definition and scope

The mission focuses on healthcare as a determinant of India's living standards and long-run resilience. Progress cannot be judged by a single headline number: outcomes must be assessed across regions, genders, income groups and access to opportunity.

Three priority constraints shape this research agenda: Access and affordability; Prevention; Rural care. Each requires a baseline, causal diagnosis and an explicit view of which levers belong to national government, state government, municipalities, enterprises or civil society.

2. Key research questions

1. What is the scale and distribution of access and affordability, and which public datasets can establish a reproducible baseline?
2. What is the scale and distribution of prevention, and which public datasets can establish a reproducible baseline?
3. What is the scale and distribution of rural care, and which public datasets can establish a reproducible baseline?
4. Which interventions show credible evidence of impact in Indian states or comparable economies?
5. What implementation costs, institutional capabilities and unintended effects must be evaluated?

3. Proposed interventions

3.1 — Stronger primary care

Design: Test stronger primary care in a limited geography or sector, using clear eligibility criteria and published operating rules. Delivery: Identify a lead implementing body, local partners, an independent evaluator and a route for citizen or business feedback. Evidence: Track a baseline, a comparison group where feasible, costs per beneficiary and quality-of-service measures.

3.2 — Interoperable digital health

Design: Test interoperable digital health in a limited geography or sector, using clear eligibility criteria and published operating rules. Delivery: Identify a lead implementing body, local partners, an independent evaluator and a route for citizen or business feedback. Evidence: Track a baseline, a comparison group where feasible, costs per beneficiary and quality-of-service measures.

3.3 — Preventive programs

Design: Test preventive programs in a limited geography or sector, using clear eligibility criteria and published operating rules. Delivery: Identify a lead implementing body, local partners, an independent evaluator and a route for citizen or business feedback. Evidence: Track a baseline, a comparison group where feasible, costs per beneficiary and quality-of-service measures.

4. Illustrative demonstration project

5. Phased implementation roadmap

6. Measurement framework

The following indicators are proposed for an MDI dashboard. Definitions, sources, frequency and disaggregation should be finalized with domain experts.

• Out-of-pocket expenditure share
• primary-care access
• maternal and child outcomes
• avoidable hospitalizations.

7. Risks, trade-offs and safeguards

Implementation risk: Ambitious national targets may obscure weak local delivery. Mitigation: publish state and district dashboards and stage investments around independent evaluations.

Equity risk: Benefits may concentrate among better-connected communities. Mitigation: track distributional outcomes and design accessibility, language and inclusion safeguards.

Measurement risk: Correlation may be mistaken for impact. Mitigation: document baselines, methods, data limitations and alternative explanations.

Financial risk: Costs may exceed expected benefits. Mitigation: assess unit economics, fiscal sustainability and opportunity costs before scaling.

8. Expert consultation agenda

1. Which assumption in this brief is weakest, and what evidence could falsify it?
2. Which state, district or industry offers the best first pilot?
3. What would a realistic five-year target look like?
4. Which institution should be accountable for the outcome?
5. What should be excluded to keep the intervention feasible?

9. Reference sources and evidence plan

• NITI Aayog — Strategic Imperatives for Viksit Bharat @2047
• NITI Aayog — DPI@2047 roadmap
• World Bank — India data
• National Health Accounts
• Ministry of Health
• WHO Global Health Observatory.

This is an original editorial working brief, not a peer-reviewed paper. It intentionally avoids presenting unsupported numerical forecasts as established facts. Consult linked primary sources for current statistics.